Literature DB >> 24411909

A novel rat model of contrast-induced acute kidney injury.

Shiqun Sun1, Tuo Zhang1, Peng Nie1, Liuhua Hu1, Ying Yu1, Mingli Cui1, Zhaohua Cai1, Linghong Shen2, Ben He3.   

Abstract

Entities:  

Keywords:  Acute kidney injury; Animal model; Contrast medium

Mesh：

Substances：

Year:  2013        PMID： 24411909     DOI： 10.1016/j.ijcard.2013.12.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  14 in total

1.  Iohexol plasma clearance, a simple and reliable method to measure renal function in conscious mice.

Authors:  Sergio Luis-Lima; Ana Elena Rodríguez-Rodríguez; Cristina Martín-Higueras; Catalina Sierra-Ramos; Fabiola Carrara; María Rosa Arnau; Diego Alvarez de la Rosa; Eduardo Salido; Flavio Gaspari; Esteban Porrini
Journal:  Pflugers Arch       Date:  2016-06-17       Impact factor: 3.657

2.  MicroRNA expression profile by next-generation sequencing in a novel rat model of contrast-induced acute kidney injury.

Authors:  Yong Liu; Bowen Liu; Yuanhui Liu; Shiqun Chen; Junqing Yang; Jin Liu; Guoli Sun; Wei-Jie Bei; Kun Wang; Zhujun Chen; Ning Tan; Jiyan Chen
Journal:  Ann Transl Med       Date:  2019-04

3.  MicroRNA-188 aggravates contrast-induced apoptosis by targeting SRSF7 in novel isotonic contrast-induced acute kidney injury rat models and renal tubular epithelial cells.

Authors:  Bowen Liu; Yunfei Chai; Wei Guo; Kaiyan Lin; Shiqun Chen; Jin Liu; Guoli Sun; Guangzhong Chen; Feier Song; Yibo He; Yan Liang; Zhaodong Guo; Li Lei; Lihao He; Liwei Liu; Ning Tan; Yong Liu; Shilong Zhong; Jiyan Chen
Journal:  Ann Transl Med       Date:  2019-08

4.  A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo.

Authors:  Tong-qiang Liu; Wei-li Luo; Xiao Tan; Yi Fang; Jing Chen; Hui Zhang; Xiao-fang Yu; Jie-ru Cai; Xiao-qiang Ding
Journal:  Oxid Med Cell Longev       Date:  2014-11-11       Impact factor: 6.543

5.  Comparison of Effects of Different Statins on Contrast-Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings.

Authors:  Xiao-Lei Wang; Tuo Zhang; Liu-Hua Hu; Shi-Qun Sun; Wei-Feng Zhang; Zhe Sun; Ling-Hong Shen; Ben He
Journal:  Oxid Med Cell Longev       Date:  2017-01-24       Impact factor: 6.543

6.  Iso-Osmolar Iodixanol Induces Less Increase in Circulating Endothelial Microparticles In Vivo and Less Endothelial Apoptosis In Vitro Compared with Low-Osmolar Iohexol.

Authors:  Beijian Zhang; Yi Zhang; Bo Liu; Lu Fang; Yigang Li; Shu Meng
Journal:  Contrast Media Mol Imaging       Date:  2018-04-10       Impact factor: 3.161

7.  A novel simple experimental model for low-osmolar contrast-induced acute kidney injury using different definitions based on the levels of serum creatinine and cystatin C.

Authors:  Yuan-Hui Liu; Jin-Hua Xue; Deng-Xuan Wu; Wei-Jie Bei; Kun Wang; Yong Liu; Ji-Yan Chen; Ning Tan
Journal:  BMC Nephrol       Date:  2019-07-04       Impact factor: 2.388

8.  Effects of thymoquinone in prevention of experimental contrast-induced nephropathy in rats.

Authors:  Ulaş Serkan Topaloğlu; Murat Hayri Sipahioğlu; İnayet Güntürk; Hülya Akgün; Muhammet Ensar Doğan; Gökhan Sönmez; Ferhan Elmalı; Cevat Yazıcı
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

9.  Circulating MicroRNA-188, -30a, and -30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury.

Authors:  Shi-Qun Sun; Tuo Zhang; Ding Ding; Wei-Feng Zhang; Xiao-Lei Wang; Zhe Sun; Liu-Hua Hu; Sheng-Ying Qin; Ling-Hong Shen; Ben He
Journal:  J Am Heart Assoc       Date:  2016-08-15       Impact factor: 5.501

10.  Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study.

Authors:  Ismail Altintop; Mehmet Tatli; Cigdem Karakukcu; Zeynep Soyer Sarica; Arzu Hanım Yay; Esra Balcioglu; Ahmet Ozturk
Journal:  Medicina (Kaunas)       Date:  2018-07-30       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.